Caveolin-1 and Bromocriptine in Pituitary Adenoma Cells
Author Information
Author(s): Jiang Yan-Nian, Li Yi-Hung, Ke Meng-Wei, Tseng Ting-Yu, Tang Yueh-Bih, Huang Mu-Chiou, Cheng Winston Teng-Kuei, Ju Yu-Ten
Primary Institution: National Taiwan University
Hypothesis
Does caveolin-1 sensitize rat pituitary adenoma GH3 cells to bromocriptine-induced apoptosis?
Conclusion
Caveolin-1 increases sensitivity for apoptosis induction in pituitary adenoma GH3 cells and may contribute to tumor shrinkage after clinical bromocriptine treatment.
Supporting Evidence
- Caveolin-1 expression was elevated after bromocriptine treatment.
- Bromocriptine treatment increased apoptosis in GH3 cells.
- Caveolin-1 induction of apoptosis was enhanced by bromocriptine.
- Phosphorylation of caveolin-1 at tyrosine 14 was increased after bromocriptine treatment.
Takeaway
Caveolin-1 helps brain tumor cells die when treated with a medicine called bromocriptine, which is used to shrink tumors.
Methodology
The study used rat pituitary adenoma GH3 cells to investigate the effects of caveolin-1 on apoptosis induced by bromocriptine treatment.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website